Correction to: Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects.

An amendment to this paper has been published and can be accessed via the original article.

Correction to: J Nanobiotechnol (2020) 18:53 10.1186/s12951-020-00600-x

Following publication of the original article [1], the authors identified errors in Fig. 8d and f. The corrected Fig. 8 and the corrected figure caption are given below.

Fig. 8

ATX-LPN partially rescue CDDP-induced hearing loss. a In vitro culture of Organ of Corti. CDDP induced a significant loss of hair cells (Myosin VII, red), especially in the high-frequency areas. b Survival outer hair cell numbers in 1 mm length at different locations from apical end of each group. *p < 0.05, **p < 0.01, ***p < 0.001 as compared with CDDP, #p < 0.05 as compared with ATX + CDDP. c–e Mean ABR threshold of mice treated with cisplatin, ATX 1 mg/ml, 5 μl. ATX-LPN + CDDP. *p < 0.05, **p < 0.01, ***p < 0.001 as compared with CDDP, #p < 0.05 as compared with ATX + CDDP. f Immunohistochemistry of cochlea in apex/middle/basal area of BM. The pretreatment of protective drugs (ATX/ATX-LPN) effectively reduced the expression of caspase-3 (red fluorescence) and rescued more OHCs (green fluorescence)